tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Gaush Meditech’s Ocular Fundus Cameras Gain Certification in China

Story Highlights
  • Gaush Meditech Ltd focuses on advanced medical devices for ophthalmic diagnostics.
  • Gaush Neotech’s ocular fundus cameras receive certification, enhancing eye health diagnostics.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Gaush Meditech’s Ocular Fundus Cameras Gain Certification in China

Claim 70% Off TipRanks Premium

Gaush Meditech Ltd. ( (HK:2407) ) just unveiled an announcement.

Gaush Meditech Ltd announced that its subsidiary, Gaush Neotech, has received a medical device registration certificate in China for its innovative ocular fundus cameras. These cameras feature advanced mydriasis-free HD imaging technology and intelligent systems, improving the efficiency and comfort of fundus examinations. This development is expected to enhance diagnostic capabilities in primary medical institutions and promote eye health screening, addressing the growing need due to an aging population and increasing chronic diseases.

More about Gaush Meditech Ltd.

Gaush Meditech Ltd is a company incorporated in the Cayman Islands, operating in the medical technology industry. It focuses on developing advanced medical devices, particularly for ophthalmic diagnostics, through its subsidiary Gaush Neotech Ltd.

Average Trading Volume: 126,218

Technical Sentiment Signal: Sell

Current Market Cap: HK$931.7M

Find detailed analytics on 2407 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1